Quantification of hepatic FOXP3+ T‐lymphocytes in HIV/hepatitis C coinfection
Open Access
- 15 August 2013
- journal article
- research article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 21 (4) , 251-259
Abstract
Summary: Coinfection with HIV adversely impacts every stage of hepatitis C (HCV) infection. Liver damage in HCV infection results from host antiviral responses rather than direct viral pathogenesis. Despite depressed cellular immunity, coinfected patients show accelerated hepatic fibrosis compared with HCV monoinfected patients. This paradox is poorly understood. T‐regulatory (Treg) cells (CD4+ and FOXP3+) are hypothesized to limit hepatic damage in HCV. Our hypothesis was that reduced frequency of hepatic Treg in HIV/HCV coinfection compared with HCV monoinfection may explain poorer outcomes. We quantified FOXP3+, CD4+, CD8+ and CD20+ cells in liver biopsies of 35 male subjects matched by age and ISHAK fibrosis score, 12 HIV monoinfected, 11 HCV monoinfected and 12 HIV/HCV coinfected. Cell counts were performed using indirect immunohistochemical staining and light microscopy. HIV/HCV coinfected subjects had fewer hepatic FOXP3+ (P = 0.031) and CD4+ cells (P = 0.001) than HCV monoinfected subjects. Coinfected subjects had more hepatic CD8+ cells compared with HCV monoinfected (P = 0.023), and a lower ratio of FOXP3+ to CD8+ cells (0.08 vs 0.27, P < 0.001). Multivariate analysis showed number of CD4+ cells controlled for differences in number of FOXP3+ cells. Fewer hepatic FOXP3+ and CD4+ cells in HIV/HCV coinfection compared with HCV monoinfection suggests lower Treg activity, driven by an overall loss of CD4+ cells. Higher number of CD8+ cells in HIV/HCV coinfection suggests higher cytotoxic activity. This may explain poorer outcomes in HIV/HCV coinfected patients and suggests a potential mechanism by which highly active antiretroviral therapy may benefit these patients.Keywords
Funding Information
- Academy of Medical Sciences
- Janssen and Gilead
- Wellcome Trust (WT091663MA)
- Oxford Martin School
- NIHR Biomedical Research Centre
- NIAID U19 Bio-defense Program (NIH NIAID 1U19AI082630-01)
- Leukaemia and Lymphoma Research
This publication has 34 references indexed in Scilit:
- Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infectionJournal of Hepatology, 2007
- Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapyHepatology, 2007
- Diminished frequency of hepatitis C virus specific interferon secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patientsGut, 2006
- The role of the transcription factor Foxp3 in the development of regulatory T cellsImmunological Reviews, 2006
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsJournal of Experimental Medicine, 2006
- FOXP3: Of Mice and MenAnnual Review of Immunology, 2006
- Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2005
- T Cells with a CD4+CD25+Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+T Cells during Chronic Hepatitis C Virus InfectionJournal of Virology, 2005
- Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patientsHepatology, 1999
- Histological Damage in Chronic Hepatitis C Is Not Related to the Extent of Infection in the LiverThe American Journal of Pathology, 1999